{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:32:51Z","timestamp":1793251971224,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007219","name":"Shanghai Municipal Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbrc.2026.154762","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:11:23Z","timestamp":1792105883000},"page":"154762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Two active components, derived from dragon's blood, elicit a synergistic antitumor immune response in hepatocellular carcinoma"],"prefix":"10.1016","volume":"840","author":[{"given":"Shudong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiusong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinchen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2711-2240","authenticated-orcid":false,"given":"Yan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154762_bib1","first-page":"498","article-title":"Advances in the treatment of hepatocellular carcinoma: an overview of the current and evolving therapeutic landscape for clinicians","volume":"75","author":"Moris","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2026.154762_bib2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2026.154762_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13045-025-01739-6","article-title":"Combination immunotherapy in hepatocellular carcinoma: synergies among immune checkpoints, TKIs, and chemotherapy","volume":"18","author":"Dai","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2026.154762_bib4","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1038\/ctg.2017.28","article-title":"Targeting the vasculature in hepatocellular carcinoma treatment: starving versus normalizing blood supply","volume":"8","author":"Liu","year":"2017","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.bbrc.2026.154762_bib5","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.apsb.2020.09.004","article-title":"Precise delivery of obeticholic acid via nanoapproach for triggering natural killer T cell-mediated liver cancer immunotherapy","volume":"10","author":"Ji","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bbrc.2026.154762_bib6","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.154762_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1470-2045(21)00604-5","article-title":"Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial","volume":"23","author":"Yau","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbrc.2026.154762_bib8","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrc.2026.154762_bib9","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.154762_bib10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nri.2017.131","article-title":"Towards personalized, tumour-specific, therapeutic vaccines for cancer","volume":"18","author":"Hu","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2026.154762_bib11","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s43018-022-00418-6","article-title":"Cancer vaccines: the next immunotherapy frontier","volume":"3","author":"Lin","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.bbrc.2026.154762_bib12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41573-024-00974-9","article-title":"Enhancing in situ cancer vaccines using delivery technologies","volume":"23","author":"Gong","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2026.154762_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202407914","article-title":"Sulfate radical based in situ vaccine boosts systemic antitumor immunity via concurrent activation of necroptosis and STING pathway","volume":"36","author":"Huang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bbrc.2026.154762_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13045-025-01692-4","article-title":"Nanomaterials-driven in situ vaccination: a novel frontier in tumor immunotherapy","volume":"18","author":"Liu","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2026.154762_bib15","doi-asserted-by":"crossref","first-page":"23517","DOI":"10.1021\/acsnano.5c09427","article-title":"Chemical construction of In Situ tumor vaccination","volume":"19","author":"Xu","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbrc.2026.154762_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41568-024-00787-3","article-title":"Dendritic cell maturation in cancer","volume":"25","author":"Moon","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2026.154762_bib17","article-title":"Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency","volume":"9","author":"Li","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbrc.2026.154762_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010157","article-title":"Degradation of PARP1 by MARCHF3 in tumor cells triggers cCAS-STING activation in dendritic cells to regulate antitumor immunity in hepatocellular carcinoma","volume":"12","author":"Cao","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbrc.2026.154762_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3835(99)00312-2","article-title":"Absence of CD83-positive mature and activated dendritic cells at cancer nodules from patients with hepatocellular carcinoma: relevance to hepatocarcinogenesis","volume":"148","author":"Chen","year":"2000","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.154762_bib20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2026.154762_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105507","article-title":"Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma","volume":"166","author":"Zheng","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2026.154762_bib22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.molmed.2023.11.002","article-title":"Reprogramming endothelial cells to empower cancer immunotherapy","volume":"30","author":"Cleveland","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbrc.2026.154762_bib23","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.3748\/wjg.v28.i42.6034","article-title":"Angiogenesis and immune checkpoint dual blockade: opportunities and challenges for hepatocellular carcinoma therapy","volume":"28","author":"Li","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbrc.2026.154762_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41698-021-00197-w","article-title":"Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients","volume":"5","author":"Boucher","year":"2021","journal-title":"Npj Precis. Onc."},{"key":"10.1016\/j.bbrc.2026.154762_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41575-022-00704-9","article-title":"Evolving therapeutic landscape of advanced hepatocellular carcinoma","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2026.154762_bib26","article-title":"The potential predictive biomarkers for advanced hepatocellular carcinoma treated with anti-angiogenic drugs in combination with PD-1 antibody","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.154762_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1005658","article-title":"Advances and challenges of immunocheckpoint inhibitors in the treatment of primary liver cancer","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.bbrc.2026.154762_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.sjbs.2012.11.005","article-title":"In vitro micropropagation of Dracaena sanderiana Sander ex Mast: an important indoor ornamental plant","volume":"20","author":"Aslam","year":"2013","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.bbrc.2026.154762_bib29","doi-asserted-by":"crossref","first-page":"10650","DOI":"10.3390\/molecules190710650","article-title":"A systematic review of the botanical, phytochemical and pharmacological profile of Dracaena cochinchinensis, a plant source of the ethnomedicine \u201cDragon's Blood,\u201d","volume":"19","author":"Fan","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2026.154762_bib30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jep.2007.10.018","article-title":"Dragon's blood: Botany, chemistry and therapeutic uses","volume":"115","author":"Gupta","year":"2008","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bbrc.2026.154762_bib31","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1093\/jn\/130.9.2127","article-title":"Phytosterols as anticancer dietary components: evidence and mechanism of action","volume":"130","author":"Awad","year":"2000","journal-title":"J. Nutr."},{"key":"10.1016\/j.bbrc.2026.154762_bib32","first-page":"24","article-title":"Application of Yang-Strengthening method in treatment of tumors from perspective of \"Yang Tansforming Qi, Yin Shaping up Body\"","volume":"43","author":"Wang","year":"2024","journal-title":"Shandong J. Tradit. Chin. Med."},{"key":"10.1016\/j.bbrc.2026.154762_bib33","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12032-025-02721-5","article-title":"Pterostilbene as a multifaceted anticancer agent: molecular mechanisms, therapeutic potential and future directions","volume":"42","author":"Ali","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bbrc.2026.154762_bib34","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3390\/antiox10030492","article-title":"Pterostilbene in cancer therapy","volume":"10","author":"Obrador","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbrc.2026.154762_bib35","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.apsb.2021.08.020","article-title":"Emerging role of natural products in cancer immunotherapy","volume":"12","author":"Dong","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bbrc.2026.154762_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13027-019-0247-4","article-title":"Resveratrol induces immunogenic cell death of human and murine ovarian carcinoma cells","volume":"14","author":"Zhang","year":"2019","journal-title":"Infect. Agents Cancer"},{"key":"10.1016\/j.bbrc.2026.154762_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2024.103193","article-title":"Protocol for screening potential targets for the treatment of hepatocellular carcinoma based on H22 tumor-bearing mouse model","volume":"5","author":"Gao","year":"2024","journal-title":"STAR Protoc."},{"key":"10.1016\/j.bbrc.2026.154762_bib38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1021\/acsnano.3c05829","article-title":"In situ nanofiber patch boosts postoperative hepatocellular carcinoma immune activation by trimodal combination therapy","volume":"18","author":"Zhao","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbrc.2026.154762_bib39","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/hep.31846","article-title":"Loss\u2010of\u2010Function genetic screening identifies aldolase A as an essential driver for liver cancer cell growth under hypoxia","volume":"74","author":"Niu","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2026.154762_bib40","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/s41416-024-02774-9","article-title":"HIV-protease inhibitors potentiate the activity of carfilzomib in triple-negative breast cancer","volume":"131","author":"Besse","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2026.154762_bib41","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1038\/s41467-020-17127-2","article-title":"Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154762_bib42","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13020-026-01344-w","article-title":"Polymeric micelle hydrogel of Resina Draconis enables mechanistically targeted protection against skin photoaging","volume":"21","author":"Liu","year":"2026","journal-title":"Chin. Med."},{"key":"10.1016\/j.bbrc.2026.154762_bib43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/imr.13269","article-title":"Immunogenic cell death (ICD) enhancers\u2014Drugs that enhance the perception of ICD by dendritic cells","volume":"321","author":"Liu","year":"2024","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbrc.2026.154762_bib44","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jconrel.2021.12.002","article-title":"Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer","volume":"341","author":"Qiu","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bbrc.2026.154762_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2023.125060","article-title":"Illustrate the distribution and metabolic regulatory effects of pterostilbene in cerebral ischemia-reperfusion rat brain by mass spectrometry imaging and spatial metabolomics","volume":"266","author":"Ban","year":"2024","journal-title":"Talanta"},{"key":"10.1016\/j.bbrc.2026.154762_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201902746","article-title":"MT1\u2010MMP\u2010Activated liposomes to improve tumor blood perfusion and drug delivery for enhanced pancreatic cancer therapy","volume":"7","author":"Wei","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bbrc.2026.154762_bib47","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.7150\/thno.36936","article-title":"TGF-\u03b2 inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity","volume":"10","author":"Panagi","year":"2020","journal-title":"Theranostics"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26015287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26015287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:00:37Z","timestamp":1793250037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26015287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":47,"alternative-id":["S0006291X26015287"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154762","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two active components, derived from dragon's blood, elicit a synergistic antitumor immune response in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154762"}}